Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI Imaging to Predict Outcomes of Treatment in PDAC Patients

NCT04700488 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.

NCT NCT04700488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04700488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI Imaging to Predict Outcomes of Treatment in PDAC Patients
Lead sponsor
Cedars-Sinai Medical Center
Phase
Not applicable
Overall status
Suspended
Start date
May 19, 2022
Completion date
January 31, 2026
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pdac - pancreatic ductal adenocarcinoma